Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 12Hyperandrogenism 3Menstruation Disturbances 2Insulin Resistance 2Overweight 1Metabolic Syndrome 1Infertility 1Hirsutism 1Amenorrhea 1

Interventions

Metformin 8Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2Clomiphene 2maltodextrin 1licogliflozin 1bicalutamide 1Yoga 1Topiramate 1Thioctic Acid 1Sodium Salicylate 1Phlebotomy 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1Glycoprotein Hormones, alpha Subunit 1Estrogens 1Doxycycline 1Dexamethasone 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hyperandrogenism × drospirenone and ethinyl estradiol combination × Clear all
NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

AGUNCO Obstetrics and Gynecology Centre

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡